| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunovant, Inc. (IMVT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $50.51M | - | |
| CFO | 247.6K | $9.62M | -10,000 | |
| COO | 224.4K | $8.72M | -17,714 | |
| Other | 218.4K | $8.49M | -40,000 | |
| Other | 218.0K | $8.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2025 | Stout Jay S63 | Chief Technology Officer | Sell | 1,925 | $14.79 | $28,470.75 | -0.9% | +24.2% | - | |
| Apr 23, 2025 | Geffner Michael66 | Chief Medical Officer | Sell | 2,349 | $14.79 | $34,741.71 | -1.0% | +24.2% | - | |
| Apr 16, 2025 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 2,993 | $14.89 | $44,565.77 | -0.7% | +17.9% | - | |
| Apr 16, 2025 | Salzmann Peter51 | Chief Executive Officer | Sell | 8,321 | $14.89 | $123,899.69 | -0.7% | +17.9% | - | |
| Apr 9, 2025 | Stout Jay S63 | Chief Technology Officer | Sell | 5,004 | $12.99 | $65,001.96 | -2.3% | +13.4% | +72.1% | |
| Apr 9, 2025 | Geffner Michael66 | Chief Medical Officer | Sell | 6,169 | $12.99 | $80,135.31 | -2.6% | +13.4% | +72.1% | |
| Apr 9, 2025 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 11,063 | $12.99 | $143,708.37 | -1.4% | +13.4% | +72.1% | |
| Apr 9, 2025 | Salzmann Peter51 | Chief Executive Officer | Sell | 28,094 | $12.99 | $364,941.06 | -2.3% | +13.4% | +72.1% | |
| Mar 7, 2025 | Fromkin Andrew J.45 | Director | Sell | 8,000 | $19.60 | $156,768.96 | -4.1% | -20.0% | +33.2% | |
| Feb 19, 2025 | MacIas William L.51 | Chief Medical Officer | Sell | 2,055 | $20.86 | $42,867.30 | -0.6% | -28.0% | +26.6% |